[Form 4] AvePoint, Inc. Insider Trading Activity

Rhea-AI Filing Summary

AvePoint Executive Chairman and Director Gong Xunkai reported a sale of 2,068,966 common shares on 09/18/2025 at $15.21 per share conducted in connection with AvePoint's secondary listing on the Singapore Exchange Securities Trading Limited (SGX-ST). The filing states the sale facilitated initial liquidity for the SGX-ST listing, was executed in accordance with Rule 144 and applicable insider trading policies, and that no shares were sold on NASDAQ. Following the transaction the reporting person beneficially owns 15,220,668 shares, comprised of shares held by affiliated LLCs and trusts for which he is trustee, with a disclaimer limiting admission of beneficial ownership.

Positive

• Transaction executed pursuant to the company's SGX-ST secondary listing, indicating a documented reason for the sale
• Sale conducted in accordance with Rule 144 and insider trading policies, per the filing
• Filing specifies no sale occurred on NASDAQ, clarifying market of execution
• Detailed breakdown of post-transaction beneficial ownership across affiliates and trusts is provided

Negative

• Executive Chairman disposed of 2,068,966 common shares, reducing his reported holdings by that amount
• Insider sale represents a material share disposition (2,068,966 shares) which investors may view as a reduction in insider-held liquidity

Insights

Securities Analyst

TL;DR: Insider sale of 2.07M shares executed for SGX-ST listing liquidity; reporting shows continued large beneficial ownership.

The filing documents a single, sizeable non-derivative disposition of 2,068,966 common shares at $15.21 on 09/18/2025 tied explicitly to AvePoint's secondary listing on SGX-ST. The report affirms compliance with Rule 144 and states no NASDAQ sales occurred. Post-transaction beneficial ownership is reported at 15,220,668 shares across affiliated entities and trusts, though the filer disclaims beneficial ownership except to the extent of pecuniary interest. For investors, this is a routine disclosure of insider liquidity tied to a cross-listing rather than an operational result; it provides clear transactional detail without additional financial metrics.

Corporate Governance Expert

TL;DR: Transaction documented with compliance language and trustee/affiliate ownership breakdown; disclosure aligns with Section 16 reporting norms.

The Form 4 identifies Gong Xunkai as Executive Chairman and Director and discloses both direct/indirect holdings and the mechanics of the sale related to the SGX-ST listing. The explanation enumerates affiliated LLCs and trusts holding reported shares and includes the standard disclaimer regarding beneficial ownership. The filing is specific about the purpose (initial liquidity for SGX-ST listing) and compliance (Rule 144), demonstrating adherence to insider disclosure and trading-plan requirements. The disclosure is concise and procedurally complete for this type of transaction.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gong Xunkai

(Last) (First) (Middle)

C/O AVEPOINT, INC.

525 WASHINGTON BOULEVARD, SUITE 1400

(Street)

JERSEY CITY NJ 07310

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AvePoint, Inc. [ AVPT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Chairman

3. Date of Earliest Transaction (Month/Day/Year)
09/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/18/2025		S		2,068,966(1)	D	$15.21	15,220,668(2)	I	Held by trusts and LLCs

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported sale of shares was made pursuant to the Company's secondary listing on the Singapore Exchange Securities Trading Limited ("SGX-ST") on September 18, 2025. The sale was executed to facilitate initial liquidity in connection with the SGX-ST listing. The reporting person undertook the transaction in accordance with Rule 144 and applicable insider trading policies. No shares were sold on NASDAQ in connection with this transaction.

2. Includes (i) 3,965,953 shares held by Mr. Gong's affiliate Giocoso Holdings LLC, (ii) 459,929 shares held by Mr. Gong's affiliate Cadenza Holdings LLC, (iii) 170,465 shares held by Mr. Gong's affiliate Vivace Holdings LLC, each of which Mr. Gong may be deemed to beneficially own, (iv) 2,011,112 shares held by The Purple Harbor Trust, for which Mr. Gong is the trustee, (v) 2,011,112 shares held by The Purple Cove Trust, for which Mr. Gong is the trustee, and (vi) 6,602,097 shares held by G Sonata Trust, for which Mr. Gong is a trustee. The Reporting Person disclaims beneficial ownership with respect to the shares held by each trust and LLC, except to the extent his pecuniary interest therein and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for the purposes of Section 16 or for any other purpose.

	/s/ Brian Michael Brown, Attorney-in-Fact	09/22/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did AvePoint (AVPT) insider Gong Xunkai sell on 09/18/2025?

The filing reports a sale of 2,068,966 common shares at $15.21 per share executed on 09/18/2025.

Why was the sale of AVPT shares executed?

The sale was executed to facilitate initial liquidity in connection with AvePoint's secondary listing on the SGX-ST, as stated in the Form 4.

Did Gong Xunkai sell shares on NASDAQ as part of this transaction?

No. The filing explicitly states no shares were sold on NASDAQ in connection with this transaction.

How many AvePoint shares does Gong Xunkai beneficially own after the sale?

The Form 4 reports 15,220,668 shares beneficially owned following the reported transaction.

What entities hold the reported shares included in Gong Xunkai's beneficial ownership?

The filing lists holdings including Giocoso Holdings LLC (3,965,953), Cadenza Holdings LLC (459,929), Vivace Holdings LLC (170,465), The Purple Harbor Trust (2,011,112), The Purple Cove Trust (2,011,112), and G Sonata Trust (6,602,097).